6505--Request for Information (RFI) - Specialty Pharmacy List - Pharmaceutical Prime Vendor (PPV) 2028
TenderZenith matches this tender's eligibility criteria against your company profile to calculate a deterministic qualification score and identify potential disqualifiers.
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Description & Project Overview
AMENDMENT 0001 Request for Information (RFI) 36E79727Q0001 Specialty Pharmacy - Pharmaceutical Prime Vendor (PPV) 2028 Purpose of Amendment: This amendment provides a list of Specialty Products on FSS Not Distributed Through PPV. Attachment: Attachment 1 Specialty Products on FSS Not Distributed Through PPV The attached list identifies specialty pharmaceutical products currently on the Federal Supply Schedule (FSS) that are not presently distributed through the Pharmaceutical Prime Vendor (PPV) program. The list is provided for reference purposes only and may include products that are subject to specialty, limited, closed, or other restricted distribution models. Inclusion on this list should not be interpreted as confirmation that a product is a Limited Distribution Drug (LDD) or Closed Distribution Product (CDP). Distribution arrangements, manufacturer requirements, and product availability may change over time; therefore, this list is not intended to be exhaustive and should be considered a point-in-time reference only. Response Date: Unchanged. Responses are due no later than 11:00 AM Central Time, November 16, 2026, via email to Karen.Ade@va.gov. All other information in the RFI remains unchanged.